Cargando…
COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections
Autores principales: | Mattiuzzi, Camilla, Lippi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802165/ https://www.ncbi.nlm.nih.gov/pubmed/35108600 http://dx.doi.org/10.1016/j.jinf.2022.01.033 |
Ejemplares similares
-
COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation
por: Mattiuzzi, Camilla, et al.
Publicado: (2022) -
COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
por: Mattiuzzi, Camilla, et al.
Publicado: (2022) -
Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?
por: Mattiuzzi, Camilla, et al.
Publicado: (2022) -
Improving Nasal Protection for Preventing SARS-CoV-2 Infection
por: Nocini, Riccardo, et al.
Publicado: (2022) -
Highly efficient respirators are needed for the Omicron variant of SARS-CoV-2
por: Mattiuzzi, C., et al.
Publicado: (2022)